WallStreetZenWallStreetZen

NASDAQ: BOLT
Bolt Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bolt Biotherapeutics earnings were -$50.7M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest BOLT earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$8.6M, down 22.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BOLT reported annual earnings of -$63.1M, with -8.8% growth.

BOLT earnings history

Current Revenue
$4.2M
Current Earnings
-$50.7M
Current Profit Margin
-1,217%

BOLT Return on Equity

Current Company
-94.4%
Current Industry
-9%
Current Market
27%
BOLT's Return on Equity (-94.4%)... subscribe to Premium to read more.
High Return on Equity Performance

BOLT undefined

Current Company
-54.8%
Current Industry
0.3%
BOLT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BOLT announces earnings.

BOLT undefined

Current Company
-80.26%
Current Industry
8.2%
BOLT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BOLT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BOLT-$47.13M-$50.71MN/A-$26.46
MLEC-$5.72M-$8.28MN/A-$2.10
APRE-$14.83M-$13.85MN/A-$2.30
LIXT-$3.31M-$3.32MN/A-$1.45
IMRNN/A-$4.62MN/A-$0.81
View Top Biotech Stocks

Bolt Biotherapeutics Earnings Reports & History FAQ

What were Bolt Biotherapeutics's earnings last quarter?

On BOLT's earnings call on Invalid Date, Bolt Biotherapeutics (NASDAQ: BOLT) reported Q2 2025 earnings per share (EPS) of -$4.46, up 59.89% year over year. Total BOLT earnings for the quarter were -$8.56 million. In the same quarter last year, Bolt Biotherapeutics's earnings per share (EPS) was -$11.12.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.

Is Bolt Biotherapeutics profitable or losing money?

As of the last Bolt Biotherapeutics earnings report, Bolt Biotherapeutics is currently losing money. Bolt Biotherapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$50.71 million, a 23.35% decrease year over year.

What was BOLT's earnings growth in the past year?

As of Bolt Biotherapeutics's earnings date in Invalid Date, Bolt Biotherapeutics's earnings has grown year over year. BOLT earnings in the past year totalled -$50.71 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.